Literature DB >> 20688250

Pauci-immune necrotizing glomerulonephritis.

Abraham Rutgers1, Jan S F Sanders, Coen A Stegeman, Cees G M Kallenberg.   

Abstract

Pauci-immune necrotizing glomerulonephritis is the most frequent cause of rapidly progressive glomerulonephritis and, in most cases, is associated with antineutrophil cytoplasmic antibodies (ANCA). It is either the renal manifestation of Wegener's granulomatosis, microscopic polyangiitis of Churg-Strauss syndrome, or a renal-limited vasculitis. In this review, the histopathologic changes seen in renal biopsies of patients with pauci-immune glomerulonephritis are described. The authors also describe why the disease is sometimes limited to the kidneys, the clinical course of renal disease, treatment issues, how to deal with disease relapses, and how to prevent them from occurring. Furthermore, the necessity of renal biopsy and rebiopsy, the usefulness of rapid ANCA detection at diagnosis, and serial measurement of ANCA during follow-up are discussed. The effect of dialysis on the disease process and the possibility of renal transplantation after disease remission are also debated. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20688250     DOI: 10.1016/j.rdc.2010.05.002

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  3 in total

Review 1.  Histopathologic classification of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis: achievements, limitations, and perspectives.

Authors:  Andrea Hinojosa-Azaola; Ariadna Jiménez-González
Journal:  Clin Rheumatol       Date:  2017-06-14       Impact factor: 2.980

2.  A Case of Colon Cancer and Pauci-Immune Crescentic Glomerulonephritis.

Authors:  David Wilhelm; Dawn Caster; Susan Coventry; Gunjan Garg
Journal:  Cureus       Date:  2022-07-29

3.  Long-term Prognosis of Anti-Neutrophil Cytoplasmic Antibody-Negative Renal Vasculitis: Cohort Study in Korea.

Authors:  Sung Woo Lee; Mi-Yeon Yu; Seon Ha Baek; Shin-Young Ahn; Sejoong Kim; Ki Young Na; Dong-Wan Chae; Ho Jun Chin
Journal:  J Korean Med Sci       Date:  2016-02-22       Impact factor: 2.153

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.